Krieger, Christine C.; Place, Robert F.; Bevilacqua, Carmine et al.
TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy PathogenesisJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. Bd. 101. H. 6. 2016 S. 2340-2347
Kahaly, George J.; Hansen, Martin P.
Type 1 diabetes associated autoimmunityAUTOIMMUNITY REVIEWS. Bd. 15. H. 7. 2016 S. 644-648
Shen, Limei; Krauthaeuser, Susanne; Fischer, Karl et al.
Vaccination with trifunctional nanoparticles that address CD8(+) dendritic cells inhibits growth of established melanomaNANOMEDICINE. Bd. 11. H. 20. 2016 S. 2647-2662
Kloeckner, Roman; Pitton, Michael B.; Dueber, Christoph et al.
Validation of Clinical Scoring Systems ART and ABCR after Transarterial Chemoembolization of Hepatocellular Carcinoma2016
Bechstein, Wolf. O.; Galle, Peter R.; Nashan, Bjoern et al.
Viral Hepatitis and Its Complications: Management of Hepatocellular CarcinomaVISCERAL MEDICINE. Bd. 32. H. 2. 2016 S. 127-130
Schmidt, F. P.; Glaser, N. J.; Schreiner, O. et al.
"Do not rescuscitate"- Consequences of the Introduction of a standardized Form of Therapy Limitations in the clinical PracticeDEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 140. H. 15. 2015 S. E159-E165
Weiler, Sofia; Wolf, Thomas; Pinna, Federico et al.
A gene signature defines chromosomal instability (CIN) and poor survival in liver cancer patientsCANCER RESEARCH. Bd. 75. 2015
Nielsen, Mette J.; Zimmermann, Tim; Karsdal, Morten A. et al.
A marker of true type III collagen formation (Pro-C3) predicts rapid fibrosis progression in post-liver transplant patientsHEPATOLOGY. Bd. 62. 2015 S. 908A-908A
Moehler, Markus Hermann; Heinemann, Volker; Obermannova, Radka et al.
A phase I, dose-finding study of orally administered S-1 in combination with epirubicin and oxaliplatin (EOS) in patients (pts) with advanced or metastatic gastrointestinal cancer (AGIC) and chemonave advanced esophagogastric cancer (AEGC)JOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 3. 2015
Zimmermann, A.; Grigorescu-Sido, P.; Rossmann, H. et al.
A PROSPECTIVE STUDY OF INSULIN RESISTANCE IN GAUCHER DISEASE TYPE 1 PATIENTS WITH NORMAL WEIGHT, UNDER ENZYME REPLACEMENT THERAPYACTA ENDOCRINOLOGICA-BUCHAREST. Bd. 11. H. 2. 2015 S. 180-188